| Expression pattern: |
DN |
| Associated gene: |
GLS / glutaminase |
| Associated microRNA: |
miR-27b-3p |
| Biological function: |
circSirt1 protects vascular smooth muscle cells against oxidative stress-induced injury, cell death and apoptosis during atherosclerosis, and promotes glutamine metabolism. |
| Molecular mechanism: |
circSirt1 functions as a miR-27b-3p sponge to relieve miR-27b-3p-mediated suppression of GLS, thereby restoring glutamine metabolism and protecting VSMCs from oxidative stress-induced injury. |
| Biological pathway or process: |
apoptosis (inhibits); glutaminolysis (promotes); ceRNA regulation (promotes); other pathway/process (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; RNA Pull-Down; Luciferase Reporter Assay; Transfection; MTT; Annexin V/PI Flow Cytometry; Western Blot |
| Clinical significance: |
circSirt1 may be a therapeutic target or approach for atherosclerosis treatment. |
| Description: |
circSirt1 is down-regulated in VSMCs from atherosclerosis patients and under oxidative stress. Its overexpression protects AoSMCs/VSMCs from oxidative stress-induced injury and apoptosis by sponging miR-27b-3p, increasing GLS expression, and restoring glutamine metabolism. The circSirt1-miR-27b-3p-GLS axis is proposed as a potential therapeutic mechanism for maintaining VSMC homeostasis in atherosclerosis. |
| Confidence score: |
0.6996 |